Journey Medical Corp. (DERM)
7.53
-0.38
(-4.80%)
USD |
NASDAQ |
Aug 25, 16:00
7.53
0.00 (0.00%)
After-Hours: 16:57
Journey Medical Shareholders Equity (Quarterly) : 32.11M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.11M |
| March 31, 2026 | 30.83M |
| December 31, 2025 | 31.85M |
| September 30, 2025 | 25.90M |
| June 30, 2025 | 19.25M |
| March 31, 2025 | 21.54M |
| December 31, 2024 | 20.07M |
| September 30, 2024 | 10.93M |
| June 30, 2024 | 11.30M |
| March 31, 2024 | 12.95M |
| December 31, 2023 | 20.35M |
| September 30, 2023 | 17.37M |
| Date | Value |
|---|---|
| June 30, 2023 | 0.005M |
| March 31, 2023 | 7.492M |
| December 31, 2022 | 16.98M |
| September 30, 2022 | 26.18M |
| June 30, 2022 | 34.80M |
| March 31, 2022 | 41.44M |
| December 31, 2021 | 42.04M |
| September 30, 2021 | -11.71M |
| June 30, 2021 | -0.792M |
| March 31, 2021 | |
| December 31, 2020 | 10.29M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 903.12M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.36M |
| Total Liabilities (Quarterly) | 66.24M |
| Debt to Equity Ratio | 0.7953 |
| Current Ratio | 1.590 |
| Net Debt Paydown Yield | -0.04% |